Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2021, Vol. 12 Issue (1) : 7-13     DOI: 10.14336/AD.2020.0929
Commentary |
Age in the Time of COVID-19: An Ethical Analysis
Sorin Hostiuc1,2,*, Ionut Negoi1,3, Oana Maria-Isailă1,2, Ioana Diaconescu2, Mihaela Hostiuc1,3, Eduard Drima4
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2National Institute of Legal Medicine, Bucharest, Romania
3Floreasca Clinical Emergency Hospital, Bucharest, Romania
4Dunărea de Jos University, Galați, Romania
Download: PDF(354 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

Despite using a myriad of methods to combat the spread of COVID-19, the healthcare systems (especially the intensive care units) have been overwhelmed, showing an outpaced capacity of available beds and ventilators. Choosing the right criteria to allocate the scarce ICU seems very challenging, being necessary a rapid, uncomplicated and universally accepted tool for patients’ triage regarding access to lifesaving resources; one such criterion, which generates intense debates, is age. Under certain circumstances, it might seem appropriate to choose to treat a young over an old patient. The main advantage of this approach is the potential for long-term survival, implying an equal right to reach an advanced age. Many authors have given moral reasons to support it, mainly based on utilitarian ethics or on distributive justice. However, there are numerous counterarguments to this approach, which we will summarize in this article. We will show that age should never be used as a unique criterion for withholding/not initiating life-saving procedures, even in pandemics or cases in which healthcare resources are extremely scarce. This approach is based on fundamental Codes of Ethics, such as the WMA Code of Ethics or the Oath of Hippocrates and all physicians treating patients should obey them.

Keywords age      morality      COVID-19      pandemic      medical futility     
Corresponding Authors: Hostiuc Sorin   
About author:

these authors contributed equally to this work.

Just Accepted Date: 30 September 2020   Issue Date: 11 January 2021
E-mail this article
E-mail Alert
Articles by authors
Hostiuc Sorin
Negoi Ionut
Maria-Isailă Oana
Diaconescu Ioana
Hostiuc Mihaela
Drima Eduard
Cite this article:   
Hostiuc Sorin,Negoi Ionut,Maria-Isailă Oana, et al. Age in the Time of COVID-19: An Ethical Analysis[J]. Aging and disease, 2021, 12(1): 7-13.
URL:     OR
[1] Rothan HA, Byrareddy SN (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 109:102433.
[2] Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. (2020). Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA, 323:1406-1407.
[3] Wang Y, Wang Y, Chen Y, Qin Q (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol, 92:568-576.
[4] Rosenbaum L (2020). Facing Covid-19 in Italy—ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med, 382:1873-1875.
[5] Vergano M, Bertolini G, Giannini A, Gristina G, Livigni S (2020). Clinical Ethics Recommendations for the Allocation of Intensive Care Treatments in Exceptional, Resource-Limited Circumstances. Recenti Prog Med, 111(4):207-211.
[6] British medical Association (2020). COVID-19 - ethical issues. A guidance note. 2020.
[7] Consejo de Salubridad General (2020). Guía Bioética para Asignación de Recursos Limitados de Medicina Crítica en Situación de Emergencia. Consejo de Salubridad General, 2020.
[8] Farrell TW, Ferrante LE, Brown T, Francis L, Widera E, Rhodes R, et al. (2020). AGS Position Statement: Resource Allocation Strategies and Age-Related Considerations in the COVID-19 Era and Beyond. J Am Geriatr Soc, 68:1136-1142.
[9] Montero-Odasso M, Hogan DB, Lam R, Madden K, MacKnight C, Molnar F, et al. (2020). Age Alone is not Adequate to Determine Health-care Resource Allocation During the COVID-19 Pandemic. Can Geriatr J, 23:152-154.
[10] Zweibel NR, Cassel CK, Karrison T (1993). Public Attitudes About the Use of Chronological Age as a Criterion for Allocating Health Care Resources1. Gerontologist, 33:74-80.
[11] Kilner JF (1988). Selecting patients when resources are limited: a study of US medical directors of kidney dialysis and transplantation facilities. Am J Public Health, 78:144-147.
[12] Callahan D Setting limits: medical goals in an aging society with “a response to my critics.” Georgetown University Press, 1995.
[13] Moody HR (1994). Four scenarios for an aging society. Hastings Cent Rep, 24:32-35.
[14] Johannesson M, Johansson PO (1996). The economics of ageing: on the attitude of Swedish people to the distribution of health care resources between the young and the old. Health Policy, 37:153-161.
[15] Daugherty Biddison EL, Faden R, Gwon HS, Mareiniss DP, Regenberg AC, Schoch-Spana M, et al. (2019). Too Many Patients… A Framework to Guide Statewide Allocation of Scarce Mechanical Ventilation During Disasters. Chest, 155:848-854.
[16] Bowling A (1996). Health care rationing: the public’s debate. BMJ, 312:670-674.
[17] Nilstun T, Ohlsson R (1995). Should health care be rationed by age? Scand J Soc Med, 23:81-84.
[18] Daniels N (1993). The Prudential Lifespan Account of Justice Between Generations. Justice Across Generations: What Does It Mean. Cambridge University Press, 257-283.
[19] Lambie R (2013). Allocation and Ageism in Aoteaora. An exploration of the ethical justification for age-based healthcare rationing. University of Otago, New Zeeland.
[20] Wareham CS (2015). Youngest First? Why it is Wrong to Discriminate Against the Elderly in Healthcare. SAJBL, 8:37-39.
[21] Cesari M, Proietti M (2020). COVID-19 in Italy: Ageism and Decision-Making in a Pandemic. J Am Med Dir Assoc, 21(5): 576-577
[22] Butler RN (1980). Ageism: A Foreword. J Soc Issues, 36:8-11.
[23] Savulescu J, Persson I, Wilkinson D (2020). Utilitarianism and the pandemic. Bioethics, 34:620-632.
[24] Stone JR (2012). Elderly and older racial/ethnic minority healthcare inequalities -- care, solidarity, and action. Camb Q Healthc Ethics, 21:342-352.
[25] DeBolt K (2010). What Will Happen to Granny-Ageism in America: Allocation of Healthcare to the Elderly & Reform through Alternative Avenues. Cal WL Rev, 47:127.
[26] Robb C, Chen H, Haley WE (2002). Ageism in Mental Health and Health Care: A Critical Review. Journal of Clinical Geropsychology, 8:1-12.
[27] Nelson TD (2005). Ageism: Prejudice Against Our Feared Future Self. J Soc Issues, 61:207-221.
[28] Onder G, Rezza G, Brusaferro S (2020). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 323:1775-1776.
[29] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395:1054-1062.
[30] Gautier SV (2017). Textbook on transplantology - «a very timely book ». Russian Journal of Transplantology and Artificial Organs, 19:5.
[31] The World Medical Association (2006). WMA International Code of Medical Ethics.
[32] De Bruin DA, Parilla E, Liaschenko J, Marshall MF, Leider JP, Brunnquell DJ, et al. (2009). Implementing ethical frameworks for rationing scarce health resources in minnesota during severe influenza pandemic. Minnesota Center for Healthcare Ethics, 2009.
[33] Collet T-H, Sykiotis GP, Aubert CE, Baumgartner C, Blum MR, Feller M, et al. (2018). Subclinical hypothyroidism: should we still treat elderly patients? Clinical implications of a new trial in primary care. Rev Med Suisse, 14:470-474.
[34] Bagenstos SR (2020). May Hospitals Withhold Ventilators from COVID-19 Patients with Pre-Existing Disabilities? Notes on the Law and Ethics of Disability-Based Medical Rationing. Notes on the Law and Ethics of Disability-Based. doi: .
doi: 10.2139/ssrn.3559926
[35] Beauchamp TL (2001), Childress JF Principles of biomedical ethics. Oxford University Press, USA, 2001.
[36] Hostiuc S Informed consent (Consimtamantul informat), 1st ed. Casa Cartii de Ştiinţă: Cluj-Napoca; 2014.
[37] Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. (2020). Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med, in press.
[38] Rusinova K, Simek J (2014). Should we relax the definition of death or the dead donor rule? Intensive Care Med, 40:917-918.
[39] Iltis AS, Cherry MJ (2010). Death Revisited: Rethinking Death and the Dead Donor Rule. J Med Philos, 35:223-241.
[1] Wen-qing Xie,Song-feng Chen,Xiao-hua Tao,Li-yang Zhang,Pei-wu Hu,Wei-li Pan,Yi-bin Fan,Yu-sheng Li. Melatonin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-related Diseases[J]. Aging and disease, 2021, 12(1): 297-307.
[2] Fangfang Zhao,Ziping Han,Rongliang Wang,Yumin Luo. Neurological Manifestations of COVID-19: Causality or Coincidence?[J]. Aging and disease, 2021, 12(1): 27-35.
[3] Shu Li,Zhi Cao,Hongxi Yang,Yuan Zhang,Fusheng Xu,Yaogang Wang. Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19[J]. Aging and disease, 2021, 12(1): 61-71.
[4] Diogo de Moraes,Brunno Vivone Buquete Paiva,Sarah Santiloni Cury,Raissa Guimarães Ludwig,João Pessoa Araújo Junior,Marcelo Alves da Silva Mori,Robson Francisco Carvalho. Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19[J]. Aging and disease, 2021, 12(1): 42-49.
[5] Yu Peng,Hongxun Tao,Senthil Kumaran Satyanarayanan,Kunlin Jin,Huanxing Su. A Comprehensive Summary of the Knowledge on COVID-19 Treatment[J]. Aging and disease, 2021, 12(1): 155-191.
[6] Anwen Shao,Danfeng Lin,Lingling Wang,Sheng Tu,Cameron Lenahan,Jianmin Zhang. Oxidative Stress at the Crossroads of Aging, Stroke and Depression[J]. Aging and disease, 2020, 11(6): 1537-1566.
[7] Yan-hong Pan,Wei-peng Wu,Xing-dong Xiong. Circular RNAs: Promising Biomarkers for Age-related Diseases[J]. Aging and disease, 2020, 11(6): 1585-1593.
[8] Yuanjian Fang,Reng Ren,Hui Shi,Lei Huang,Cameron Lenahan,Qin Lu,Lihui Tang,Yi Huang,Jiping Tang,Jianmin Zhang,John H Zhang. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke[J]. Aging and disease, 2020, 11(6): 1496-1512.
[9] Ann Liebert,Brian Bicknell,Wayne Markman,Hosen Kiat. A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19[J]. Aging and disease, 2020, 11(6): 1352-1362.
[10] Ya Yang,Yalei Zhao,Fen Zhang,Lingjian Zhang,Lanjuan Li. COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies[J]. Aging and disease, 2020, 11(6): 1481-1495.
[11] Carly Welch,Carolyn Greig,Tahir Masud,Daisy Wilson,Thomas A Jackson. COVID-19 and Acute Sarcopenia[J]. Aging and disease, 2020, 11(6): 1345-1351.
[12] Zhang Xinmu,Li Lin. The Significance of 8-oxoGsn in Aging-Related Diseases[J]. Aging and disease, 2020, 11(5): 1329-1338.
[13] Lin Yu,Fu Ying,Zeng Yi-Fang,Hu Jian-Ping,Lin Xiao-Zhen,Cai Nai-Qing,Weng Qiang,Zhao Yi-Jing,Lin Yi,Cao Dai-Rong,Wang Ning. Six Visual Rating Scales as A Biomarker for Monitoring Atrophied Brain Volume in Parkinson’s Disease[J]. Aging and disease, 2020, 11(5): 1082-1090.
[14] Peng Zhang,Qian Su,Xiaomiao Ye,Ping Guan,Chengjun Chen,Yanwen Hang,Jian Dong,Zhongjie Xu,Wei Hu. Trends in LDL-C and Non-HDL-C Levels with Age[J]. Aging and disease, 2020, 11(5): 1046-1057.
[15] Li Xiaohua,He Shikun,Zhao Mingwei. An Updated Review of the Epigenetic Mechanism Underlying the Pathogenesis of Age-related Macular Degeneration[J]. Aging and disease, 2020, 11(5): 1219-1234.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd